Literature DB >> 28509124

Metastatic renal cell carcinoma with undetectable renal mass presenting as lymphadenopathy.

Mohamed Salah Fayaz1, Aishah Ebrahim Al-Qaderi1, Mustafa Shawki El-Sherify2.   

Abstract

Renal cell carcinoma has the ability to metastasize to any organ; about 16 % of affected patients present initially with metastasis. However, it is rare for this tumor to present with metastasis from an unidentified primary. The current use of immunohistochemistry and molecular genetics has enabled clinicians to reach a precise diagnosis. It has been hypothesized that the treatment protocol for metastatic renal cell carcinoma can be applied to cases with undetectable primary. In this paper, a novel case of metastatic renal cell carcinoma presenting with lymphadenopathy with no evidence of a primary renal lesion is reported from Kuwait cancer center.

Entities:  

Keywords:  Cancer of unknown primary; Clear cell carcinoma; Metastatic renal cell carcinoma; Pazopanib; mRCC

Year:  2016        PMID: 28509124      PMCID: PMC5438804          DOI: 10.1007/s13730-016-0239-9

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  15 in total

1.  CDKNA2A mutation analysis, protein expression, and deletion mapping of chromosome 9p in conventional clear-cell renal carcinomas: evidence for a second tumor suppressor gene proximal to CDKN2A.

Authors:  P Schraml; K Struckmann; R Bednar; W Fu; T Gasser; K Wilber; J Kononen; G Sauter; M J Mihatsch; H Moch
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

Review 2.  Immunohistochemical diagnosis of renal neoplasms.

Authors:  Luan D Truong; Steven S Shen
Journal:  Arch Pathol Lab Med       Date:  2011-01       Impact factor: 5.534

Review 3.  Role of immunohistochemistry in diagnosing renal neoplasms: when is it really useful?

Authors:  Steven S Shen; Luan D Truong; Marina Scarpelli; Antonio Lopez-Beltran
Journal:  Arch Pathol Lab Med       Date:  2012-04       Impact factor: 5.534

4.  Pazopanib versus sunitinib in metastatic renal-cell carcinoma.

Authors:  Robert J Motzer; Thomas E Hutson; David Cella; James Reeves; Robert Hawkins; Jun Guo; Paul Nathan; Michael Staehler; Paul de Souza; Jaime R Merchan; Ekaterini Boleti; Kate Fife; Jie Jin; Robert Jones; Hirotsugu Uemura; Ugo De Giorgi; Ulrika Harmenberg; Jinwan Wang; Cora N Sternberg; Keith Deen; Lauren McCann; Michelle D Hackshaw; Rocco Crescenzo; Lini N Pandite; Toni K Choueiri
Journal:  N Engl J Med       Date:  2013-08-22       Impact factor: 91.245

5.  Metastatic renal cell carcinoma, with a radiographically occult primary tumor, presenting in the operative site of a thoracic meningioma: long-term follow-up: Case report.

Authors:  Robert F Heary; Nitin Agarwal; James C Barrese; Maureen T Barry; Ada Baisre
Journal:  J Neurosurg Spine       Date:  2014-07-11

6.  Metastatic renal cell carcinoma without evidence of a renal primary.

Authors:  Corey Costantino; George V Thomas; Christopher Ryan; Fergus V Coakley; Megan L Troxell
Journal:  Int Urol Nephrol       Date:  2015-11-02       Impact factor: 2.370

7.  Metastatic cutaneous head and neck renal cell carcinoma with no known primary: case report.

Authors:  Satyajeet Bhatia; Selwyn Ng; Simon C Hodder
Journal:  Br J Oral Maxillofac Surg       Date:  2009-12-24       Impact factor: 1.651

8.  Genomic characterisation of two cancers of unknown primary cases supports a kidney cancer origin.

Authors:  Elizabeth Y Wei; Ying-Bei Chen; James J Hsieh
Journal:  BMJ Case Rep       Date:  2015-10-22

9.  Papillary Renal Carcinoma Presenting as a Cancer of Unknown Primary (CUP) and Diagnosed through Gene Expression Profiling.

Authors:  Steven M Sorscher; Frank Anthony Greco
Journal:  Case Rep Oncol       Date:  2012-05-10

10.  Metastatic renal cell carcinoma in a supraclavicular lymph node with no known primary: a case report.

Authors:  Young-Rak Choi; Hye-Suk Han; Ok-Jun Lee; Sung-Nam Lim; Mi-Jin Kim; Myeong-Ho Yeon; Hyun-Jung Jeon; Ki Hyeong Lee; Seung Taik Kim
Journal:  Cancer Res Treat       Date:  2012-09-30       Impact factor: 4.679

View more
  1 in total

1.  HMGA2 facilitates epithelial-mesenchymal transition in renal cell carcinoma by regulating the TGF-β/Smad2 signaling pathway.

Authors:  Bo Kou; Wei Liu; Xiaoshuang Tang; Qingshan Kou
Journal:  Oncol Rep       Date:  2017-11-10       Impact factor: 3.906

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.